Drug intelligence / Profile preview

HepaSphere

Development stage
Unknown
Lead developer
Merit Medical Systems
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intra-arterial
01

Overview

HepaSphere is a superabsorbent polymer (SAP) microsphere designed for use as a drug-eluting embolic agent in transarterial chemoembolization (TACE) and other embolization procedures. It is packaged dry and expands up to four times its original size upon hydration. The unique structure allows it to rapidly absorb aqueous solutions such as contrast media or chemotherapeutic agents like doxorubicin or irinotecan, which are then loaded throughout the sphere via ionic and mechanical bonds. Once delivered intra-arterially, HepaSphere provides targeted occlusion of tumor-feeding blood vessels while enabling sustained local release of the loaded chemotherapy over days to weeks. This results in high intratumoral drug concentrations with reduced systemic exposure and toxicity compared to conventional TACE methods. Its conformability allows adaptation to vessel morphology for effective embolization with fewer adverse events[1][2][3][4][5][6].

Brand names
HepaSphere
Other names
superabsorbent polymer microsphereSAP microspheredrug-eluting microsphere

Beyond the preview

Go deeper on HepaSphere.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HepaSphere.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call